Company Overview - Novanta Inc. (NASDAQ:NOVT) is a technology solutions company specializing in precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions [2][3] - The company has a market capitalization of $5.2 billion [2] Financial Performance - On February 18, 2026, Novanta Inc. stock closed at $145.63 per share [2] - The one-month return for Novanta Inc. was 5.29%, and its shares increased by 1.98% over the past twelve months [2] - In the fourth quarter of 2025, Novanta Inc. reported strong earnings with double-digit growth in its Advanced Surgery business [3] Market Position and Demand - Novanta Inc. experienced a 17% year-over-year growth in bookings, indicating robust future demand as customer inventory levels normalize [3] - The company is noted for its ability to exceed profit expectations while navigating a complex macro environment, showcasing the durability of its diversified, high-quality business model [3] Investment Sentiment - Novanta Inc. is not among the 30 most popular stocks among hedge funds, with 27 hedge fund portfolios holding the stock at the end of the third quarter, unchanged from the previous quarter [4] - While the potential of Novanta Inc. as an investment is acknowledged, certain AI stocks are considered to offer greater upside potential and less downside risk [4]